These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 24861828)

  • 1. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
    Caan B; LaCroix AZ; Joffe H; Guthrie KA; Larson JC; Carpenter JS; Cohen LS; Freeman EW; Manson JE; Newton K; Reed S; Rexrode K; Shifren J; Sternfeld B; Ensrud K
    Menopause; 2015 Jun; 22(6):607-15. PubMed ID: 25405571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
    Guthrie KA; LaCroix AZ; Ensrud KE; Joffe H; Newton KM; Reed SD; Caan B; Carpenter JS; Cohen LS; Freeman EW; Larson JC; Manson JE; Rexrode K; Skaar TC; Sternfeld B; Anderson GL
    Obstet Gynecol; 2015 Aug; 126(2):413-422. PubMed ID: 26241433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
    Ensrud KE; Guthrie KA; Hohensee C; Caan B; Carpenter JS; Freeman EW; LaCroix AZ; Landis CA; Manson J; Newton KM; Otte J; Reed SD; Shifren JL; Sternfeld B; Woods NF; Joffe H
    Sleep; 2015 Jan; 38(1):97-108. PubMed ID: 25325454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.
    Reed SD; Mitchell CM; Joffe H; Cohen L; Shifren JL; Newton KM; Freeman EW; Larson JC; Manson JE; LaCroix AZ; Guthrie KA
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):233-241. PubMed ID: 25004335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
    Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
    JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
    Joffe H; Guthrie KA; Larson J; Cohen LS; Carpenter JS; Lacroix AZ; Freeman EW
    Menopause; 2013 Mar; 20(3):261-8. PubMed ID: 23435022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.
    Newton KM; Carpenter JS; Guthrie KA; Anderson GL; Caan B; Cohen LS; Ensrud KE; Freeman EW; Joffe H; Sternfeld B; Reed SD; Sherman S; Sammel MD; Kroenke K; Larson JC; Lacroix AZ
    Menopause; 2014 Jan; 21(1):45-58. PubMed ID: 23760428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials.
    Guthrie KA; Larson JC; Ensrud KE; Anderson GL; Carpenter JS; Freeman EW; Joffe H; LaCroix AZ; Manson JE; Morin CM; Newton KM; Otte J; Reed SD; McCurry SM
    Sleep; 2018 Jan; 41(1):. PubMed ID: 29165623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial.
    Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D
    JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
    Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
    J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concern about the use of venlafaxine to treat vasomotor symptoms.
    Zhou SS; Lun YZ; Li D
    JAMA Intern Med; 2015 Apr; 175(4):657-8. PubMed ID: 25844750
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
    Joffe H; LaCroix AZ; Cohen L
    JAMA Intern Med; 2015 Apr; 175(4):658-9. PubMed ID: 25844753
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
    Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
    Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
    Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
    Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
    Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.
    Constantine GD; Revicki DA; Kagan R; Simon JA; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):513-519. PubMed ID: 30516713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.